| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003405A2 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | WO1995003403A1 Methods and compositions incorporating ip-10 |
| 02/02/1995 | WO1995003335A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | WO1995003333A2 Tryptase inhibitor |
| 02/02/1995 | WO1995003332A1 Activated human factor viii and method of preparation |
| 02/02/1995 | WO1995003330A1 Somatostatin derivatives and their radiolabelled products |
| 02/02/1995 | WO1995003329A2 Selective amylin antagonist peptides and uses therefor |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003327A2 Peptides for neutralizing the toxicity of lipid a |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003325A1 Protegrins |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003322A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | WO1995003289A1 Benzo-fused lactams promote release of growth hormone |
| 02/02/1995 | WO1995003281A1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists |
| 02/02/1995 | WO1995003083A1 Drug delivery |
| 02/02/1995 | WO1995003068A1 Method for administering hemoglobin |
| 02/02/1995 | WO1995003067A1 Pharmaceutical with immunomodulating activity |
| 02/02/1995 | WO1995003065A1 Scorpion peptide with immunosuppressant activity |
| 02/02/1995 | WO1995003064A1 Polymeric carriers for non-covalent drug conjugation |
| 02/02/1995 | WO1995003063A1 Oral pharmaceutical compositions comprising reduced glutathion |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | WO1995003034A1 Stabilization of aerosolized proteins |
| 02/02/1995 | WO1995003009A1 Method of treatment of macular degeneration |
| 02/02/1995 | WO1995002967A1 Viscous liquid xylitol compositions and method for preparing same |
| 02/02/1995 | WO1994029446A3 Intracellular binding proteins and use thereof |
| 02/02/1995 | WO1994029350A3 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/02/1995 | WO1994026723A3 ras FARNESYL TRANSFERASE INHIBITORS |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/02/1995 | CA2168232A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | CA2168110A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | CA2168096A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | CA2167574A1 Polymeric carriers for non-covalent drug conjugation |
| 02/02/1995 | CA2167538A1 Stabilization of aerosolized proteins |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167301A1 Selective amylin antagonist peptides and uses therefor |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166870A1 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | CA2166788A1 Protegrins |
| 02/02/1995 | CA2166616A1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/02/1995 | CA2164221A1 Tryptase inhibitor |
| 02/01/1995 | EP0636360A1 Cosmetic composition containing an association of a superoxide dismutase and a melanin pigment |
| 02/01/1995 | EP0636182A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
| 02/01/1995 | EP0636180A1 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/01/1995 | EP0636178A1 Protocadherin, their autibodies and uses |
| 02/01/1995 | EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636175A1 Decorin fragments and methods of inhibiting cell regulatory factors |
| 02/01/1995 | EP0636174A1 Hyaluronan receptor (rhamm = receptor for hyluronan mediated mobility) and hyaluronan binding peptides |
| 02/01/1995 | EP0636173A1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 02/01/1995 | EP0636171A1 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells |
| 02/01/1995 | EP0636144A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
| 02/01/1995 | EP0636142A1 Lactam peptides having hle inhibiting activity |
| 02/01/1995 | EP0636140A1 Partially modified and retro-inverted tetrapeptides analogues of c-reactive protein fragments. |
| 02/01/1995 | EP0636032A1 Method of intraoperatively detecting and locating tumoral tissues |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |
| 02/01/1995 | EP0535150B1 Human macrophage inflammatory protein 2-beta |
| 02/01/1995 | EP0473649B1 Biologically active polypeptides based on transforming growth factor-beta sequences |
| 02/01/1995 | CN1098140A Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 02/01/1995 | CN1098105A Novel material, dolastachin C and application of same |
| 02/01/1995 | CN1097984A Methods for administering biological agents and microparticle compositions useful in these and other methods |
| 01/31/1995 | US5386025 Calcium channel compositions and methods |
| 01/31/1995 | US5386014 Reducing and deoxygenating bovine hemoglobin; conjugation to activated polyalkylene oxide in presence of chloride anions |
| 01/31/1995 | US5386012 Growth factor in connection with artificial implants |
| 01/31/1995 | US5386011 Hexapeptide anaphylatoxin-receptor ligands |
| 01/31/1995 | US5386010 Water-soluble, inhalable echinocandins; fungicides; antiprotozoa agents, yeasts |
| 01/31/1995 | US5386009 Water-soluble, injectible echinocandins; fungicides; antiprotozoa agents, yeasts |
| 01/31/1995 | US5385937 Preventing peroxide generation from mercaptan groups and endothelial injury |
| 01/31/1995 | US5385918 Aminomethylene-peptides as immunosuppressants |
| 01/31/1995 | US5385904 Therapy for immunology diseases |
| 01/31/1995 | US5385890 Improved solubility; mixture with polyoxyethylene glycol sorbital alkyl ester |
| 01/31/1995 | US5385889 Substitution of L-proline at the 7-position of the peptide hormone with a D-configuration hydroxyproline ether or thioether converts agonist into antagonist |
| 01/31/1995 | US5385888 Class I MHC modulation or surface receptor activity |
| 01/31/1995 | US5385887 Protein, sugar, glycine, glutamic acid hydrochloride |
| 01/31/1995 | US5385885 Inhibition of smooth muscle cell proliferation by antistasin and tick anticoagulant peptide |
| 01/31/1995 | US5385884 Water-soluble, injectible echinocandins; fungicides; antiprotozoa agents, yeasts |
| 01/31/1995 | US5385840 Respiratory system |
| 01/31/1995 | US5385740 Biologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereof |
| 01/31/1995 | US5385738 Sustained-release injection |
| 01/31/1995 | US5385731 Method of treating hyperlipidemia with granulocyte colony stimulating factor |
| 01/31/1995 | CA1334180C Antibiotics r106 |
| 01/30/1995 | CA2126523A1 Jak kinases and regulation of cytokine signal transduction |
| 01/26/1995 | WO1995002751A1 Method for repairing a combustion chamber assembly |
| 01/26/1995 | WO1995002693A1 Bacillus thuringiensis isolates and toxins |
| 01/26/1995 | WO1995002692A1 Modified alpha-lactalbumin |
| 01/26/1995 | WO1995002686A1 Redirection of cellular immunity by receptor chimeras |
| 01/26/1995 | WO1995002610A1 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 01/26/1995 | WO1995002609A1 Peptides exhibiting oxytocin antagonistic activity |
| 01/26/1995 | WO1995002608A1 Novel cholecystokinin and gastrin receptor ligands, production method therefor and pharmaceutical compositions containing same |
| 01/26/1995 | WO1995002421A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| 01/26/1995 | WO1995002420A2 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | WO1995002414A1 Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products |
| 01/26/1995 | WO1995002413A1 Suppression of inhibitors |
| 01/26/1995 | WO1995002411A1 Stabilised polypeptide growth factor formulation at low ph |